Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report. [PDF]
Fry J +10 more
europepmc +1 more source
Effective high-dose methotrexate toxicity reversal using fixed-dose glucarpidase in obese patients: a case series. [PDF]
Grofvert J +4 more
europepmc +1 more source
SGLT2 Inhibitors in Mitigating Cancer Therapy-Related Cardiac Dysfunction: Expanding the Evidence. [PDF]
Dabour MS, Blaes AH, Ramu B, Zordoky BN.
europepmc +1 more source
Glucarpidase efficacy in mitigating methotrexate toxicity is unaffected by concurrent administration of folinic acid. [PDF]
Wahlestedt M +5 more
europepmc +1 more source
Bradyarrhythmias Associated with Oncologic Treatment-An Updated Review. [PDF]
Stępień J +5 more
europepmc +1 more source
Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicity in Cancer Survivors: From Bench to Bedside. [PDF]
Tao S, Yu L, Zhang L, Li J, Wu J, Tan Y.
europepmc +1 more source
Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis. [PDF]
El-Helbawy A +6 more
europepmc +1 more source
Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society. [PDF]
Keramida K +10 more
europepmc +1 more source
Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase. [PDF]
Purzycki T, Knapp M, Patel S.
europepmc +1 more source
Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology. [PDF]
Jayaraman A, Stacy MR.
europepmc +1 more source

